LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 10.46 | 27.76 | 1150 | 438 | 2.6217 | 1.5477 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.17 | 27.76 | 219 | 489 | 0.4478 | 0.6471 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.17 | 27.76 | 998 | 489 | 2.0406 | 1.3761 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.17 | 27.76 | 17 | 489 | 0.0348 | -0.1117 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.17 | 27.76 | 1222 | 489 | 2.4986 | 1.4953 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.87 | 27.76 | 759 | 604 | 1.2551 | 1.1049 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.87 | 27.76 | 1056 | 604 | 1.7463 | 1.2672 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.87 | 27.76 | 317 | 604 | 0.5242 | 0.7295 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.87 | 27.76 | 1303 | 604 | 2.1547 | 1.3770 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 15.58 | 27.76 | 963 | 685 | 1.4047 | 1.1524 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 15.58 | 27.76 | 1112 | 685 | 1.6220 | 1.2204 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 15.58 | 27.76 | 407 | 685 | 0.5937 | 0.7868 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 15.58 | 27.76 | 1370 | 685 | 1.9983 | 1.3228 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.28 | 27.76 | 1083 | 838 | 1.2913 | 1.1067 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.28 | 27.76 | 1193 | 838 | 1.4224 | 1.1486 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.28 | 27.76 | 1056 | 838 | 1.2591 | 1.0959 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.28 | 27.76 | 1515 | 838 | 1.8063 | 1.2556 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.98 | 27.76 | 1182 | 941 | 1.2559 | 1.0917 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.98 | 27.76 | 1275 | 941 | 1.3547 | 1.1231 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.98 | 27.76 | 1200 | 941 | 1.2750 | 1.0979 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.98 | 27.76 | 1634 | 941 | 1.7362 | 1.2293 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.68 | 27.76 | 1283 | 1119 | 1.1466 | 1.0520 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.68 | 27.76 | 1358 | 1119 | 1.2136 | 1.0739 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.68 | 27.76 | 1478 | 1119 | 1.3208 | 1.1071 | MN20160318_Q01 | N08 |